Exagen Inc (XGN) — Cash Flow Reinvestment Rate
Latest as of September 2025:
0.19x
Exagen Inc (XGN) has a Cash Flow Reinvestment Rate of 0.19x as of September 2025, reinvesting $550.00K (capex $275.00K plus investments $-275.00K) from operating cash flow of $2.94 Million. Explore reinvestment intensity of Exagen Inc to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
0.19x
(Capex + Investments) / Operating CF
Total Reinvested
$550.00K
Capex + Investments
Operating Cash Flow
$2.94 Million
USD
Capital Expenditures
$275.00K
USD
Annual Cash Flow Reinvestment Rate for Exagen Inc (None–None)
Year-by-year capital reinvestment analysis for Exagen Inc. For live market cap and broader valuation context, see Exagen Inc market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow